Oxford spin-out @AlethioTx, a #biopharmaceutical company developing next-generation #therapies for myeloproliferative neoplasms (MPNs), has completed an oversubscribed €80.46 million Series A financing. 🇬🇧 🧬 🩸
Big Picture Bio, a London-based #BioTech#startup developing AI-designed combination #therapies for #cancer and other complex diseases, has emerged from #stealth with a combined #funding round of €2.55 million. 🇬🇧 🧬🤖💊
Revier Therapeutics, a Heidelberg-based #BioTech company advancing disease-modifying #therapies for patients with #cardiometabolic disease, has launched and closed a €6 million #Seed financing round. 🇩🇪🫀🧬💊
Immitra Bio, a Zürich-based #genetic#medicine platform bringing scalability and commercial viability to #gene#editing#therapies, has announced the completion of an upsized €2.58 million pre-Seed #financing round. 🇨🇭🧬🔬
